Udslættet var oftest let eller moderat, generelt makuløst til makulopapuløst eller erytematøst, optrådte hyppigst i anden behandlingsuge og var sjældent efter uge 4.
Rash was most frequently mild to moderate, generally macular to maculopapular or erythematous, mostly occurred in the second week of therapy, and was infrequent after week 4.